4 analysts have shared their evaluations of 4D Molecular Therapeutics (NASDAQ:FDMT) during the recent three months, expressing a mix of bullish and bearish perspectives. The table below offers a ...
FOR more info, visit the PCSO 4D Lotto page.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback